BRPI0411248A - método para produzir um polipeptìdeo - Google Patents

método para produzir um polipeptìdeo

Info

Publication number
BRPI0411248A
BRPI0411248A BRPI0411248-2A BRPI0411248A BRPI0411248A BR PI0411248 A BRPI0411248 A BR PI0411248A BR PI0411248 A BRPI0411248 A BR PI0411248A BR PI0411248 A BRPI0411248 A BR PI0411248A
Authority
BR
Brazil
Prior art keywords
polypeptide
producing
cytokine antagonist
antagonist polypeptide
expressing
Prior art date
Application number
BRPI0411248-2A
Other languages
English (en)
Inventor
Clive R Wood
Patricia Murtha-Riel
Gene W Lee
Mark Leonard
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0411248A publication Critical patent/BRPI0411248A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MéTODO PARA PRODUZIR UM POLIPEPTìDEO". São expostos métodos de produção de um polipeptídeo antagonista de citocina por co-expressão do polipeptídeo antagonista de citocina com um ácido nucléico que codifica um polipeptídeo complexo para o polipeptídeo antagonista de citocina.
BRPI0411248-2A 2003-06-11 2004-06-14 método para produzir um polipeptìdeo BRPI0411248A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47754803P 2003-06-11 2003-06-11
PCT/US2004/018753 WO2005014646A1 (en) 2003-06-11 2004-06-14 Method for producing a polypeptide

Publications (1)

Publication Number Publication Date
BRPI0411248A true BRPI0411248A (pt) 2006-07-25

Family

ID=34135046

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411248-2A BRPI0411248A (pt) 2003-06-11 2004-06-14 método para produzir um polipeptìdeo

Country Status (10)

Country Link
US (1) US20050118683A1 (pt)
EP (1) EP1664114A1 (pt)
JP (1) JP2007530009A (pt)
CN (1) CN1823089A (pt)
AU (1) AU2004262637A1 (pt)
BR (1) BRPI0411248A (pt)
CA (1) CA2528569A1 (pt)
IL (1) IL172332A0 (pt)
MX (1) MXPA05013508A (pt)
WO (1) WO2005014646A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009114693A1 (en) * 2008-03-12 2009-09-17 Wyeth Method for identifying cells suitable for large-scale production of recombinant proteins
KR20240052871A (ko) 2016-04-27 2024-04-23 애브비 인코포레이티드 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법
KR20240036508A (ko) * 2021-05-13 2024-03-20 포지 바이올로직스, 인크. 아데노바이러스성 헬퍼 플라스미드
EP4536684A1 (en) * 2022-06-13 2025-04-16 B.A.I. Laboratories, LLC Interleukin-13 binding cyclic oligopeptides and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
GB0004016D0 (en) * 2000-02-22 2000-04-12 Royal Brompton Hospital Biological material and uses thereof
WO2001077332A2 (en) * 2000-04-07 2001-10-18 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors

Also Published As

Publication number Publication date
EP1664114A1 (en) 2006-06-07
AU2004262637A1 (en) 2005-02-17
MXPA05013508A (es) 2006-04-05
CA2528569A1 (en) 2005-02-17
WO2005014646A1 (en) 2005-02-17
US20050118683A1 (en) 2005-06-02
CN1823089A (zh) 2006-08-23
IL172332A0 (en) 2009-02-11
JP2007530009A (ja) 2007-11-01

Similar Documents

Publication Publication Date Title
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
ATE438638T1 (de) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
BRPI0416744A (pt) sistemas de expressão de proteìna aperfeiçoados
BR0312121A (pt) xinalases, ácidos nucléicos codificando-as e métodos para preparar e empregá-las
BRPI0417107A (pt) fragmento de anticorpo, métodos de preparação do fragmento de anticorpo, ácido nucléico isolado, composições, célula hospedeira e métodos de fabricação e de geração de fragmento de anticorpo
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
BRPI0415505A (pt) agente terapêutico para mesotelioma
DE60233147D1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
EA200701192A1 (ru) Антагонисты toll-подобного рецептора 3, способы их получения и применение
BRPI0415361A (pt) antagonistas do receptor muscarìnico de acetilcolina
NI200800193A (es) Anticuerpos humanos anti-il-23, composiciones, métodos y usos.
BR0308211A (pt) Cumarinas úteis como biomarcadores
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
BRPI0410031A (pt) variantes fc otimizadas e métodos para sua geração
BR0314917A (pt) Método e sistema para produzir coloração de um objeto produzido por prototipagem rápida e método de compensação de bicos não-funcionais
BR0211293B1 (pt) processo para produzir continuamente uma composição elastomérica.
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
ATE517094T1 (de) Verfahren zur herstellung von medetomidin und seinen salzen
BR0204916B1 (pt) mÉtodo para produzir uma olefina.
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
BRPI0417992A (pt) método para purificar fsh
BR0016632A (pt) Métodos e composições para a fabricação de lentes oftálmicas
EA200301292A1 (ru) Способ синтеза тропенола для его получения в промышленном масштабе
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]